🔴 Tiger’s Red-Hot Innovator of the Week: Dutch startup plugs the knee treatment gap

Every Monday I share a startup that I really like. I call it the Red-Hot Innovator of the Week.

There isn’t a good orthopedic solution for every patient. Particularly in knees.

Under 40 years with a contained chondral defect? You still have a shot with cells, scaffolds, OATS, or MACI. Over 60 years with collapsed compartments? UKA or TKA is the honest answer.

The problem is the patient in the middle: the 40- to 60-year-old who is too biologically old for reliable cartilage regeneration and far too young for a metal-and-poly joint they will have to revise twice. That is the treatment gap. Avalanche Medical is aiming a polymer plug straight at it. Website: https://avalanchemedical.com/ The Clinical Bind Nobody Likes to Admit

Leave it alone: Leave a full-thickness femoral defect alone and it does not stay focal. It becomes tricompartmental OA. Try to regenerate it: In a 50-year-old, the biology fights you. Chondrocyte yield drops. Cells senesce. Subchondral bone remodels. Two-year MRI looks encouraging; 5- and 10-year curves do not. Jump to arthroplasty: You have bought a revision problem. A primary TKA at 50 almost guarantees at least one, and often two, uglier reconstructions ...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top